Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 2
2005 4
2006 2
2007 2
2008 2
2009 1
2010 3
2011 7
2012 4
2013 10
2014 5
2015 4
2016 5
2017 7
2018 6
2019 5
2020 4
2021 5
2022 4
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
In-vehicle Sensing and Data Analysis for Older Drivers with Mild Cognitive Impairment.
Moshfeghi S, Jan MT, Conniff J, Ghoreishi SGA, Jang J, Furht B, Yang K, Rosselli M, Newman D, Tappen R, Smith D. Moshfeghi S, et al. Among authors: smith d. 2023 IEEE 20th Int Conf Smart Communities Improv Qual Life Using AI Robot IoT HONET (2023). 2023 Dec;2023:140-145. doi: 10.1109/HONET59747.2023.10374639. 2023 IEEE 20th Int Conf Smart Communities Improv Qual Life Using AI Robot IoT HONET (2023). 2023. PMID: 38562260 Free PMC article.
Selective D3 receptor antagonism modulates neural response during negative emotional processing in substance dependence.
Vamvakopoulou IA, Fonville L, Hayes A, McGonigle J, Elliott R, Ersche KD, Flechais R, Orban C, Murphy A, Smith DG, Suckling J, Taylor EM, Deakin B, Robbins TW, Nutt DJ, Lingford-Hughes AR, Paterson LM. Vamvakopoulou IA, et al. Among authors: smith dg. Front Psychiatry. 2022 Oct 19;13:998844. doi: 10.3389/fpsyt.2022.998844. eCollection 2022. Front Psychiatry. 2022. PMID: 36339857 Free PMC article.
Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia.
Goswami M, Gui G, Dillon LW, Lindblad KE, Thompson J, Valdez J, Kim DY, Ghannam JY, Oetjen KA, Destefano CB, Smith DM, Tekleab H, Li Y, Dagur P, Hughes T, Marté JL, Del Rivero J, Klubo-Gwiezdzinksa J, Gulley JL, Calvo KR, Lai C, Hourigan CS. Goswami M, et al. Among authors: smith dm. J Immunother Cancer. 2022 Jan;10(1):e003392. doi: 10.1136/jitc-2021-003392. J Immunother Cancer. 2022. PMID: 35017151 Free PMC article.
72 results